Personal information

Russia

Activities

Works (3)

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

The Lancet Diabetes and Endocrinology
2019 | Journal article
EID:

2-s2.0-85067290095

Part of ISSN: 22138595 22138587
Contributors: Mosenzon, O.; Blicher, T.M.; Rosenlund, S.; Eriksson, J.W.; Heller, S.; Hels, O.H.; Pratley, R.; Sathyapalan, T.; Desouza, C.; Abramof, R. et al.
Source: Self-asserted source
Khavra Astamirova via Scopus - Elsevier

Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus

Diabetes Research and Clinical Practice
2018-11 | Journal article
Contributors: A. Philis-Tsimikas; K. Astamirova; Y. Gupta; A. Haggag; D. Roula; B.A. Bak; E.G. Fita; A. Moller Nielsen; T. Demir
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Treatment of diabetic nephropathy with low-molecular heparin -sulodexide

Terapevticheskii Arkhiv
1998 | Journal article
EID:

2-s2.0-0031627018

Part of ISSN: 00403660
Contributors: Zalevskaya, A.G.; Astamirova, Kh.S.; Karpova, I.A.; Popova, S.C.
Source: Self-asserted source
Khavra Astamirova via Scopus - Elsevier